Incyte Insider Form 144 Lists 3,501 Restricted Shares for Sale

Rhea-AI Filing Summary

Incyte Corporation (INCY) submitted a Form 144 notifying a proposed sale of 3,501 restricted shares valued at $299,464.34, to be executed through Morgan Stanley Smith Barney LLC on 10/03/2025 on NASDAQ. The shares were acquired as restricted stock from the issuer on 10/02/2025 and the filer reports 195,276,145 shares outstanding for the issuer.

The filing lists prior insider sales by Sheila Denton over the past three months totaling 6,165 shares across seven transactions, with gross proceeds shown for each sale (largest single prior sale: 3,330 shares for $232,633.80 on 07/15/2025). The notice includes the standard signature representation that the seller has no undisclosed material adverse information and names the executing broker and address.

Positive

• Compliance with Rule 144 disclosed: broker, proposed sale date, and acquisition details are provided
• Full transaction history for the past three months is listed, showing transparency of insider sales

Negative

• Insider sale planned of 3,501 restricted shares valued at $299,464.34
• Multiple recent insider disposals: 6,165 shares sold across seven transactions in the past three months

Insights

Corporate Governance Analyst

TL;DR: Insider intends to sell 3,501 restricted shares valued at $299,464.34, with multiple recent small insider sales disclosed.

This Form 144 documents a planned sale under Rule 144 using Morgan Stanley Smith Barney LLC and confirms the securities were issued as restricted stock on 10/02/2025. The filing fulfills disclosure requirements by listing the broker, proposed sale date 10/03/2025, and outstanding shares 195,276,145.

The record of seven prior sales by Sheila Denton in the past three months totaling 6,165 shares provides context on recent insider liquidity. This is factual reporting of transactions; the filing does not state any undisclosed material information or trading plan adoption date.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	3501	299464.34	195276145	10/03/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	10/02/2025	Restricted Stock	ISSUER			3501	10/02/2025	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
SHEILA DENTON 1801 Augustine Cut-Off Wilmington DE 19803	Common	10/02/2025	599	52502.35
SHEILA DENTON 1801 Augustine Cut-Off Wilmington DE 19803	Common	09/16/2025	278	23115.70
SHEILA DENTON 1801 Augustine Cut-Off Wilmington DE 19803	Common	09/02/2025	598	50812.06
SHEILA DENTON 1801 Augustine Cut-Off Wilmington DE 19803	Common	08/15/2025	277	24046.37
SHEILA DENTON 1801 Augustine Cut-Off Wilmington DE 19803	Common	08/04/2025	598	45310.46
SHEILA DENTON 1801 Augustine Cut-Off Wilmington DE 19803	Common	07/16/2025	785	53662.60
SHEILA DENTON 1801 Augustine Cut-Off Wilmington DE 19803	Common	07/15/2025	3330	232633.80

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the INCY Form 144 disclose?

The filing discloses a proposed sale of 3,501 restricted shares valued at $299,464.34, to be executed on 10/03/2025 via Morgan Stanley Smith Barney LLC on NASDAQ.

When were the shares to be sold by INCY acquired?

The 3,501 shares were acquired as restricted stock from the issuer on 10/02/2025.

How many shares does INCY report outstanding in the filing?

The filing reports 195,276,145 shares outstanding for the issuer.

What recent insider sales does the INCY filing show?

It lists seven sales by Sheila Denton from 07/15/2025 to 10/02/2025, totaling 6,165 shares with individual gross proceeds reported.

Does the filing state any 10b5-1 plan adoption date?

No date of a Rule 10b5-1 plan adoption or instruction is provided in the filing.